Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Cell kill kinetics with hydroxyurea.

X Yataganas, A Strife, A Perez

Medical and Pediatric Oncology

|January 1, 1976

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Playing with carbon and silicon at the nanoscale.

Nature materials·2007

Same author

Effect of pioglitazone in combination with insulin therapy on glycaemic control, insulin dose requirement and lipid profile in patients with type 2 diabetes previously poorly controlled with combination therapy.

Diabetes, obesity & metabolism·2007

Same author

Health risk behaviors and work injury among hispanic adolescents and farmworkers.

Journal of agricultural safety and health·2007

Same author

Significantly increased lifespan and improved behavioral performances by rAAV gene delivery in adult mucopolysaccharidosis IIIB mice.

Gene therapy·2007

Same author

[Allocation of resources in patients with bad prognosis: the need for debate].

Medicina intensiva·2007

Same author

[Supraorbital neuralgia: an interventionist alternative].

Revista de neurologia·2007

Same journal

Kaposiform hemangioendothelioma and therapy with interferon-alpha.

Medical and pediatric oncology·2003

Same journal

Importance of informed consent in offering to return research results to research participants.

Medical and pediatric oncology·2003

Same journal

Tumor lysis syndrome and neuroblastoma.

Medical and pediatric oncology·2003

Same journal

High incidence of brain tumors of childhood in Hungary between 1989 and 2001.

Medical and pediatric oncology·2003

Same journal

Surviving childhood cancer: what next? Issues under consideration at the After Completion of Therapy (ACT) clinic in India.

Medical and pediatric oncology·2003

Same journal

Local control in childhood extremity sarcomas: salvaging limbs and sparing function.

Medical and pediatric oncology·2003

See all related articles

Hydroxyurea (HU) alters cell cycle progression in human lymphoid cells, causing G1 arrest and S phase accumulation. Cellular injury from HU is generally more reversible than from arabinosylcytosine.

Area of Science:

Cell Biology
Molecular Biology
Pharmacology

Background:

Hydroxyurea (HU) is a known S-phase inhibitor.
Understanding HU's effects on cell cycle dynamics is crucial for its therapeutic applications.

Purpose of the Study:

To investigate the effects of various hydroxyurea concentrations on human lymphoid cells.
To analyze cell cycle redistribution and recovery post-treatment.

Main Methods:

Flow microfluorimetry for DNA content analysis.
Cell counting (total and viable).
Mitotic index and thymidine incorporation assays.

Main Results:

Hydroxyurea (HU) induced cell cycle redistribution, including G2 division and S phase depletion.

Related Experiment Videos

Accumulation of cells in early S phase and G1 arrest in surviving populations.

Post-treatment recovery was concentration and duration-dependent, with generally reversible injury.

Conclusions:

Hydroxyurea causes significant cell cycle perturbations.
Cellular recovery from HU treatment is possible but depends on exposure parameters.
HU-induced cellular injury appears more reversible compared to arabinosylcytosine.